US FDA consults on draft guidance on requesting humanitarian use device designation
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration is seeking feedback on draft guidance on how medtech applicants can prepare and submit requests to receive a humanitarian use device (HUD) designation for products.